Precision Biology Solutions

Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions.

Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics though rare cell analysis.

Explore Spatial Biology Insights →

Liquid Biopsy for Rare Cells →

GIRF 2024 Annual Ball

RareCyte is honored to support the vital work of the GI Research Foundation and partners to cure digestive diseases
2024 GIRF Annual Ball Video
Watch the video ➝

Eszter Papp

Webinar: New discoveries in HER2 detection: A novel method of multimodal detection of HER2 from a single tube of blood
Presented by Eszter Papp, PhD, CellCarta
Now available on demand ➝


RareCyte® secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
Read the press release ➝

Precision Spatial Biology
Powered by Orion

Break barriers with the fastest path to whole-slide, highly multiplexed biomarker imaging data. Orion brings biomarker depth and flexibility with the convenience of a single-step stain and image process.

Discover the Orion Platform →

Read the latest on Orion →

Orion Imaging System

Liquid Biopsy Solutions

Investigate circulating tumor cell (CTC) biomarker expression and mutational status using a non-invasive liquid biopsy. Obtain sensitive, accurate, and reproducible results utilizing a complete end-to-end workflow, from blood collection to single-cell isolation.

Discover the Liquid Biopsy Platform →

Explore CTC applications →

HER2/ER image panel

Dedicated Lab Services

RareCyte enables class-leading performance in CTC applications and Spatial Biology solutions supporting therapy selection, disease-monitoring, and global research and clinical trials.

"Using their liquid biopsy imaging technology, RareCyte was able to develop a custom assay. Throughout the process, the RareCyte team was collaborative and insightful, showing true dedication to the project, resulting in the development of a fully validated assay."

Erica Tobin
Associate Director, Oncology
KSQ Therapeutics, Inc.

Start My Program →

CyteFinder® Imaging

Enable rapid, high-throughput fluorescence imaging with CyteFinder II HT, and rare cell identification with single-cell retrieval with the CyteFinder II.

CyteFinder II Imaging System

Learn More →


Dr Sara McArdle

Webinar: Use of open-source software for quantitative analysis of multiplex images
Presented by Dr. Sara McArdle,, La Jolla Institute of Immunology
Watch the webinar ➝

Dr Pashtoon Kasi

Nature Oncogene publication: Neoadjuvant botensilimab plus balstilimab response pattern investigated
Dr. Pashtoon Kasi, Weill Cornell Medicine
Read the publication ➝
Read the GI Research Foundation's article ➝


Measuring versus reading - Yale CLIA test transforming the field of quantitative pathology
Read interview with Dr Rimm ➝
Watch Yale Grand Rounds video ➝

View All News →

View All Events →


Need a refill of AccuCyte BCTs or a new biomarker panel kit? Select from our list of products to begin the order process.

Start My Order →

For instrument orders and service programs, please Contact Us directly.